Clinical Trial Update: GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line [Phase 2]

View source ↗

Summary

Phase 2 trial of GW786034 in third-line non-small cell lung cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GW786034

Snippet

Sponsor: Illinois CancerCare, P.C. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-19